Gulf Pharmaceutical Industries

Equities

JULPHAR

AEG000201018

Pharmaceuticals

Market Closed - Abu Dhabi Securities Exchange 06:55:00 2024-04-26 am EDT 5-day change 1st Jan Change
0.942 AED +1.40% Intraday chart for Gulf Pharmaceutical Industries -1.88% +22.50%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Gulf Pharmaceutical Industries Shares to be Suspended Ahead of Annual General Meeting MT
Abu Dhabi's Gulf Pharmaceutical Industries Resumes Trading Following FY23 Results Publication MT
Gulf Pharmaceutical Industries' FY23 Attributable Loss Widens; Revenue Up MT
Gulf Pharmaceutical Industries to Halt Trading During Board Meeting MT
Gulf Pharmaceutical Industries P.S.C. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Gulf Pharmaceutical Industries P.S.C. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Gulf Pharmaceutical Industries P.S.C. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Gulf Pharmaceutical Industries P.S.C. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Gulf Pharmaceutical Industries P.S.C. Approves Board Appointments CI
Gulf Pharmaceutical Industries P.S.C. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Gulf Pharmaceutical Industries P.S.C. Announces Chief Executive Officer Changes CI
Gulf Pharmaceutical Industries P.S.C. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Gulf Pharmaceutical Industries P.S.C. Announces Resignation of Sanjay Deshmukh as Chief Operating Officer CI
Gulf Pharmaceutical Industries P.S.C. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Cigalah Group completed the acquisition of 51% stake in Alpha Pharma L.L.C. from Gulf Pharmaceutical Industries P.S.C.. CI
Gulf Pharmaceutical Industries P.S.C. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Gulf Pharmaceutical Industries P.S.C. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Gulf Pharmaceutical Industries Announces the Resignation of Ragheb Alshakhshir as Chief Scientific Officer CI
Quantum Genomics Société Anonyme Signs an Exclusive License and Production Agreement with Gulf Pharmaceuticals Industries Julphar CI
Quantum Genomics Société Anonyme announced that it expects to receive $2 million in funding from Gulf Pharmaceutical Industries P.S.C. CI
Gulf Pharmaceutical Industries P.S.C. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
GlobalOne Healthcare acquired Gulf Inject LLC from Gulf Pharmaceutical Industries P.S.C. CI
Gulf Pharmaceutical Industries P.S.C. completed the acquisition of remaining 60% stake in Planet Pharmacies LLC from KAMCO Investment Company K.S.C.P. and others for AED 286 million CI
Cigalah Group agreed to acquire 51% stake in Alpha Pharma L.L.C. from Gulf Pharmaceutical Industries P.S.C.. CI
Gulf Pharmaceutical Industries P.S.C. agreed to acquire a 60% stake in Planet Pharmacies LLC for AED 286 million. CI
Chart Gulf Pharmaceutical Industries
More charts
Gulf Pharmaceutical Industries PSC (Julphar) is a United Arab Emirates-based public shareholding company engaged in manufacturing and selling of medicines, drugs and other types of pharmaceutical and medical compounds, in addition to cosmetic compounds. The Company maintains a range of product portfolio, which target major therapeutic segments, including endocrinology, anti-infective, cardiovascular and gastroenterology, over-the-counter, nephrology, dermatology, respiratory, metabolic and burn and wound management. The Company operates through a network of more than 10 manufacturing plants, and a logistics network. The Company has approximately 800 products in various dosage forms, and more in the pipeline. The Company’s subsidiaries include Mena Cool FZE, which is engaged in the transportation, and Julphar Pharmaceuticals PLC, which is engaged in Manufacturing of medicines, wrapping and packing materials.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
0.942 AED
Average target price
0.72 AED
Spread / Average Target
-23.57%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. JULPHAR Stock
  4. News Gulf Pharmaceutical Industries
  5. Gulf Pharmaceutical Industries' FY23 Attributable Loss Widens; Revenue Up